Antioxidant properties of high-density lipoproteins are impaired in women with polycystic ovary syndrome

Fertility and Sterility

Volumn 103, Issue 5, 2015, Pages 1346-1354

  Zhang, Jinxia ^a   Zhang, Yujin ^a   Liu, Hongwei ^a   Bai, Huai ^a   Wang, Ying ^a   Jiang, Changan ^a   Fan, Ping ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

dysfunctional high density lipoprotein; dyslipidemia; inflammation; oxidative stress; Polycystic ovary syndrome

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; MALONALDEHYDE; TRIACYLGLYCEROL; ANTIOXIDANT; APOA1 PROTEIN, HUMAN; BIOLOGICAL MARKER; HDL-TRIGLYCERIDE;

ADULT; ANOVULATION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HIGH RISK PATIENT; HUMAN; HYPERANDROGENISM; INFLAMMATION; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NORMAL VALUE; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; UNIVERSITY HOSPITAL; BLOOD; OXIDATION REDUCTION REACTION; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

ADULT; ANTIOXIDANTS; APOLIPOPROTEIN A-I; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFLAMMATION; LIPOPROTEINS, HDL; MALONDIALDEHYDE; OXIDATION-REDUCTION; OXIDATIVE STRESS; POLYCYSTIC OVARY SYNDROME; TRIGLYCERIDES; YOUNG ADULT;

EID: 84929509942     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2015.02.024     Document Type: Article

References (53)

1. W.A. March, V.M. Moore, K.J. Willson, D.I. Phillips, R.J. Norman, and M.J. Davies The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria Hum Reprod 25 2010 544 551
2. S.S. Lim, M.J. Davies, R.J. Norman, and L.J. Moran Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis Hum Reprod Update 18 2012 618 637
3. J. Zhang, P. Fan, H. Liu, H. Bai, Y. Wang, and F. Zhang Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west chinese women with PCOS Hum Reprod 27 2012 2484 2493
4. M. Murri, M. Luque-Ramirez, M. Insenser, M. Ojeda-Ojeda, and H.F. Escobar-Morreale Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis Hum Reprod Update 19 2013 268 288
5. P. Fan, H. Liu, Y. Wang, F. Zhang, and H. Bai Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS Reprod Biomed Online 24 2012 197 205
6. A. Repaci, A. Gambineri, and R. Pasquali The role of low-grade inflammation in the polycystic ovary syndrome Mol Cell Endocrinol 335 2011 30 41
7. L.J. Moran, M.L. Misso, R.A. Wild, and R.J. Norman Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis Hum Reprod Update 16 2010 347 363
8. A. Dokras Cardiovascular disease risk in women with PCOS Steroids 78 2013 773 776
9. P.C. de Groot, O.M. Dekkers, J.A. Romijn, S.W. Dieben, and F.M. Helmerhorst PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis Hum Reprod Update 17 2011 495 500
10. M.O. Goodarzi Looking for polycystic ovary syndrome genes: rational and best strategy Semin Reprod Med 26 2008 5 13
11. M. Navab, G.M. Ananthramaiah, S.T. Reddy, B.J. Van Lenten, B.J. Ansell, and G.C. Fonarow The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL J Lipid Res 45 2004 993 1007
12. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witztum Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med 320 1989 915 924
13. B.J. Ansell, K.E. Watson, A.M. Fogelman, M. Navab, and G.C. Fonarow High-density lipoprotein function recent advances J Am Coll Cardiol 46 2005 1792 1798
14. C. Bergt, J.F. Oram, and J.W. Heinecke Oxidized HDL: the paradox-idation of lipoproteins Arterioscler Thromb Vasc Biol 23 2003 1488 1490
15. V.W. Bowry, K.K. Stanley, and R. Stocker High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors Proc Natl Acad Sci U S A 89 1992 10316 10320
16. B. Hansel, A. Kontush, D. Bonnefont-Rousselot, E. Bruckert, and M.J. Chapman Alterations in lipoprotein defense against oxidative stress in metabolic syndrome Curr Atheroscler Rep 8 2006 501 509
17. C. Morgantini, A. Natali, B. Boldrini, S. Imaizumi, M. Navab, and A.M. Fogelman Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes Diabetes 60 2011 2617 2623
18. T. Kelesidis, J.S. Currier, D. Huynh, D. Meriwether, C. Charles-Schoeman, and S.T. Reddy A biochemical fluorometric method for assessing the oxidative properties of HDL J Lipid Res 52 2011 2341 2351
19. M. Navab, S.Y. Hama, G.P. Hough, G. Subbanagounder, S.T. Reddy, and A.M. Fogelman A cell-free assay for detecting hdl that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids J Lipid Res 42 2001 1308 1317
20. P.J. Patel, A.V. Khera, K. Jafri, R.L. Wilensky, and D.J. Rader The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease J Am Coll Cardiol 58 2011 2068 2075
21. P. Fan, H.W. Liu, D.H. Wan, Y. Li, Q. Song, and H. Bai Altered distribution of plasma platelet-activating factor acetylhydrolase between high-density lipoprotein and low-density lipoprotein in patients with polycystic ovary syndrome Fertil Steril 92 2009 2054 2057
22. Y. Wang, H. Liu, P. Fan, H. Bai, J. Zhang, and F. Zhang Evidence for association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome in southwest Chinese women Eur J Endocrinol 166 2012 877 885
23. P. Fan, H.W. Liu, X.S. Wang, F. Zhang, Q. Song, and Q. Li Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome Hum Reprod 25 2010 1288 1294
24. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Fertil Steril 81 2004 19 25
25. L. Falsetti, A. Gambera, and G. Tisi Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome Hum Reprod 16 2001 36 42
26. P.E. Pochi, A.R. Shalita, J.S. Strauss, S.B. Webster, W.J. Cunliffe, and H.I. Katz Report of the consensus conference on acne classification. Washington, D.C., March 24 and 25, 1990 J Am Acad Dermatol 24 1991 495 500
27. H.W. Liu, F. Zhang, P. Fan, H. Bai, J.X. Zhang, and Y. Wang Effects of apolipoprotein E genotypes on metabolic profile and oxidative stress in south-west Chinese women with polycystic ovary syndrome Eur J Obstet Gynecol Reprod Biol 170 2013 146 151
28. M. Guo, Z.J. Chen, N.S. Macklon, Y.H. Shi, H.E. Westerveld, and M.J. Eijkemans Cardiovascular and metabolic characteristics of infertile chinese women with PCOS diagnosed according to the Rotterdam consensus criteria Reprod Biomed Online 21 2010 572 580
29. Y. Robert, F. Dubrulle, L. Gaillandre, Y. Ardaens, P. Thomas-Desrousseaux, and L. Lemaitre Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification Fertil Steril 64 1995 307 312
30. B. Zhang, P. Fan, E. Shimoji, H. Itabe, S. Miura, and Y. Uehara Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration Atherosclerosis 186 2006 291 301
31. S.C. Rumsey, N.F. Galeano, Y. Arad, and R.J. Deckelbaum Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low density lipoproteins J Lipid Res 33 1992 1551 1561
32. B.J. Ansell, M. Navab, S. Hama, N. Kamranpour, G. Fonarow, and G. Hough Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment Circulation 108 2003 2751 2756
33. A. Roe, J. Hillman, S. Butts, M. Smith, D. Rader, and M. Playford Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS J Clin Endocrinol Metab 99 2014 E841 E847
34. R.A. Wild, M. Rizzo, S. Clifton, and E. Carmina Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis Fertil Steril 95 2011 1073 1079
35. M. Navab, S.T. Reddy, B.J. Van Lenten, and A.M. Fogelman HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms Nat Rev Cardiol 8 2011 222 232
36. G.H. Rothblat, and M.C. Phillips High-density lipoprotein heterogeneity and function in reverse cholesterol transport Curr Opin Lipidol 21 2010 229 238
37. J.F. Turrens Mitochondrial formation of reactive oxygen species J Physiol 552 2003 335 344
38. A. Kontush, and M.J. Chapman Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis Pharmacol Rev 58 2006 342 374
39. A. Kontush, S. Chantepie, and M.J. Chapman Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress Arterioscler Thromb Vasc Biol 23 2003 1881 1888
40. C. Castelo-Branco, F. Steinvarcel, A. Osorio, C. Ros, and J. Balasch Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism Gynecol Endocrinol 26 2010 736 742
41. F. Gonzalez, K.S. Nair, J.K. Daniels, E. Basal, J.M. Schimke, and H.E. Blair Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidative stress in lean reproductive-age women J Clin Endocrinol Metab 97 2012 2836 2843
42. F. Gonzalez, C.L. Sia, M.K. Shepard, N.S. Rote, and J. Minium Hyperglycemia-induced oxidative stress is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome Hum Reprod 27 2012 3560 3568
43. P.H. Kodaman, and A.J. Duleba Statins in the treatment of polycystic ovary syndrome Semin Reprod Med 26 2008 127 138
44. A. Dokras, M. Bochner, E. Hollinrake, S. Markham, B. Vanvoorhis, and D.H. Jagasia Screening women with polycystic ovary syndrome for metabolic syndrome Obstet Gynecol 106 2005 131 137
45. A. Kontush, and M.J. Chapman Antiatherogenic small, dense HDL-guardian angel of the arterial wall? Nat Clin Pract Cardiovasc Med 3 2006 144 153
46. Z. Vajo, J.G. Terry, and E.A. Brinton Increased intra-abdominal fat may lower HDL levels by increasing the fractional catabolic rate of Lp A-I in postmenopausal women Atherosclerosis 160 2002 495 501
47. H.J. Teede, S.K. Hutchison, and S. Zoungas The management of insulin resistance in polycystic ovary syndrome Trends Endocrinol Metab 18 2007 273 279
48. B.R. Bhavnani, and F.Z. Stanczyk Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action J Steroid Biochem Mol Biol 142 2014 16 29
49. A. Hockerstedt, M. Jauhiainen, and M.J. Tikkanen Lecithin/cholesterol acyltransferase induces estradiol esterification in high-density lipoprotein, increasing its antioxidant potential J Clin Endocrinol Metab 89 2004 5088 5093
50. V. Zago, S. Sanguinetti, F. Brites, G. Berg, J. Verona, and F. Basilio Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women Atherosclerosis 177 2004 203 210
51. A. Topcuoglu, H. Uzun, S. Aydin, N. Kahraman, S. Vehid, and G. Zeybek The effect of hormone replacement therapy on oxidized low density lipoprotein levels and paraoxonase activity in postmenopausal women Tohoku J Exp Med 205 2005 79 86
52. W.H. Sutherland, P.J. Manning, S.A. de Jong, A.R. Allum, S.D. Jones, and S.M. Williams Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women Metabolism 50 2001 319 324
53. R.Y. Man, L.K. Ting, S. Fan, M.M. Lau, Y.L. Siow, and Y.H. Chung Effect of postmenopausal hormone replacement therapy on lipoprotein and homocysteine levels in chinese women Mol Cell Biochem 225 2001 129 134